Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016.
Implantable neurostimulation devices are widely used to treat pain management, parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%.
North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Neurostimulation Devices market will register a 11.2% CAGR in terms of revenue, the global market size will reach US$ 8120 million by 2024, from US$ 4290 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurostimulation Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Neurostimulation Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Urinary and Fecal Incontinence
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Middle East and Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
St. Jude Medical (Abbott)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Neurostimulation Devices consumption (value and volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neurostimulation Devices market by identifying its various subsegments.
Focuses on the key global Neurostimulation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurostimulation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurostimulation Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Single User License - Only one user can access this report at time, users are not allowed to take a print out of the report PDF.
Enterprise User License - This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish to receive the hard copy version of this report.
Multi User License - This license will be allowing up to five users have access to the product. The report will be emailed to you. The report is sent in PDF format.
Site License - This is a site license, allowing all users within a given geographical location of your organisation access to the product. The report will be emailed to you. The report is sent in PDF format.